<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04283201</url>
  </required_header>
  <id_info>
    <org_study_id>0118U002166</org_study_id>
    <nct_id>NCT04283201</nct_id>
  </id_info>
  <brief_title>Type 2 Diabetes Mellitus Prevention Ukraine</brief_title>
  <acronym>T2DPUA</acronym>
  <official_title>Development, Implementation and Evaluation of the Effectiveness of Recommendations for the Prevention of Type 2 Diabetes in Ukraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Komisarenko Institute of Endocrinology and Metobolism</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Komisarenko Institute of Endocrinology and Metobolism</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Development, implementation and evaluation of the effectiveness of lifestyle recommendations
      for the prevention of type 2 diabetes in rural population of Ukraine
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Persons with impaired fasting plasma blood glucose levels and / or impaired glucose tolerance
      will receive personalized recommendations for diet and physical activity. Plasma blood
      glucose levels will be monitored periodically.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 20, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New type 2 diabetes cases</measure>
    <time_frame>3 month</time_frame>
    <description>fasting blood glucose level &gt;=6.1 mmol/l</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Evaluation of Lifestyle Modification for the Prevention of Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical activity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lifestyle modification</intervention_name>
    <description>Macronutrient and physical activity evaluation and modification</description>
    <arm_group_label>Diet</arm_group_label>
    <arm_group_label>Physical activity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Persons with impaired fasting plasma blood glucose levels and / or impaired glucose
        tolerance

        Exclusion Criteria:

        Known diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor Kravchenko, PhD, Prof</last_name>
    <role>Study Director</role>
    <affiliation>V.P.Komisarenko Institute of Endocrinology and Metabolism</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>V.P.Komisarenko Institute of Endocrinology and Metabolism</name>
      <address>
        <city>Kyiv</city>
        <zip>04114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ukraine</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 20, 2020</study_first_submitted>
  <study_first_submitted_qc>February 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2020</study_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Komisarenko Institute of Endocrinology and Metobolism</investigator_affiliation>
    <investigator_full_name>Mykola Khalangot</investigator_full_name>
    <investigator_title>Clinical Professor, Senior Researcher</investigator_title>
  </responsible_party>
  <keyword>lifestyle modification</keyword>
  <keyword>type 2 diabetes</keyword>
  <keyword>prevention</keyword>
  <keyword>Ukraine</keyword>
  <keyword>Rural</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

